Prudential Financial Inc Sorrento Therapeutics, Inc. Transaction History

Prudential Financial Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $1,864 - $4,611	2,520 Added 10.86%	25,725 $0
Q3 2022 Nov 04, 2022	BUY	$1.51 - $2.88 $634 - $1,209	420 Added 1.84%	23,205 $37,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $4,550 - $8,551	3,670 Added 19.2%	22,785 $45,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $2,022 - $3,145	-435 Reduced 2.23%	19,115 $89,000
Q3 2021 Nov 15, 2021	BUY	$7.41 - $10.99 $9,262 - $13,737	1,250 Added 6.83%	19,550 $149,000
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $11,366 - $17,900	1,790 Added 10.84%	18,300 $177,000
Q1 2021 May 12, 2021	BUY	$7.03 - $16.51 $1,054 - $2,476	150 Added 0.92%	16,510 $137,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $16,848 - $34,953	2,925 Added 21.77%	16,360 $112,000
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $82,893 - $252,846	13,435 New	13,435 $150,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.